{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T05:23:54Z","timestamp":1731043434064,"version":"3.28.0"},"reference-count":20,"publisher":"Texas Heart Institute Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"abstract":"Interventional cardiologists have few data on which to base clinical decisions regarding optimal care for ST-segment-elevation myocardial infarction patients who are taking therapeutic chronic oral anticoagulation. We present what we believe to be the first reported case of emergency coronary angiography and primary percutaneous coronary intervention in an ST-segment-elevation myocardial infarction patient who was on a dabigatran regimen for atrial fibrillation. The patient tolerated the procedures well and had no observable bleeding sequelae. In addition to the patient's case, we discuss the current evidence regarding the periprocedural management of oral anticoagulation in patients who need coronary angiography and percutaneous coronary intervention.<\/jats:p>","DOI":"10.14503\/thij-13-3727","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T18:32:40Z","timestamp":1427913160000},"page":"158-161","source":"Crossref","is-referenced-by-count":0,"title":["Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in a Patient Taking Dabigatran for Chronic Anticoagulation"],"prefix":"10.14503","volume":"42","author":[{"given":"Imdad","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Voyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5628","reference":[{"issue":"4","key":"i0730-2347-42-2-158-b1","series-title":"J Am Coll Cardiol","first-page":"e78","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","year":"2013","unstructured":"American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions, O'GaraPT, KushnerFG, AscheimDD, CaseyDEJr, \n et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2013;61(4):e78\u2013140."},{"issue":"7","key":"i0730-2347-42-2-158-b2","series-title":"JAMA","first-page":"767","article-title":"Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995\u20132006","volume":"302","year":"2009","unstructured":"Krumholz\n HM, \n \n Wang\n Y, \n \n Chen\n J, \n \n Drye\n EE, \n \n Spertus\n JA, \n \n Ross\n JS, \n \n et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995\u20132006. JAMA2009;302(7):767\u201373."},{"issue":"24","key":"i0730-2347-42-2-158-b3","series-title":"J Am Coll Cardiol","first-page":"2221","article-title":"American College Cardiology Foundation\/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: a report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine","volume":"59","year":"2012","unstructured":"Bashore\n TM, \n \n Balter\n S, \n \n Barac\n A, \n \n Byrne\n JG, \n \n Cavendish\n JJ, \n \n Chambers\n CE, \n \n et al. American College Cardiology Foundation\/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: a report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. J Am Coll Cardiol2012;59(24):2221\u2013305."},{"issue":"2 Suppl","key":"i0730-2347-42-2-158-b4","series-title":"Chest","first-page":"e326S","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published erratum appears in Chest 2012;141(4):1129]","volume":"141","year":"2012","unstructured":"Douketis\n JD, \n \n Spyropoulos\n AC, \n \n Spencer\n FA, \n \n Mayr\n M, \n \n Jaffer\n AK, \n \n Eckman\n MH, \n \n et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [published erratum appears in Chest 2012;141(4):1129]. Chest2012;141(2 Suppl):e326S\u201350S."},{"issue":"7","key":"i0730-2347-42-2-158-b5","series-title":"Circulation","first-page":"875","article-title":"2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"126","year":"2012","unstructured":"2012 Writing Committee Members, JneidH, AndersonJL, WrightRS, AdamsCD, BridgesCR, \n et al. 2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation2012;126(7):875\u2013910."},{"key":"i0730-2347-42-2-158-b6","unstructured":"Janssen Pharmaceuticals Inc. Xarelto package insert [Internet]. Available from: http:\/\/www.xareltohcp.com\/sites\/default\/files\/pdf\/xarelto_0.pdf [2015 Jan; cited 2015 Feb 10].","article-title":"Xarelto package insert [Internet]"},{"key":"i0730-2347-42-2-158-b7","unstructured":"Bristol-Myers Squibb Company. Eliquis package insert [Internet]. Available from: http:\/\/packageinserts.bms.com\/pi\/pi_eliquis.pdf [2014 Aug; cited 2015 Feb 10].","article-title":"Eliquis package insert [Internet]"},{"issue":"1","key":"i0730-2347-42-2-158-b8","series-title":"Catheter Cardiovasc Interv","first-page":"44","article-title":"Percutaneous coronary intervention in anticoagulated patients via radial artery access","volume":"73","year":"2009","unstructured":"Helft\n G, \n \n Dambrin\n G, \n \n Zaman\n A, \n \n Le Feuvre\n C, \n \n Barthelemy\n O, \n \n Beygui\n F, \n \n et al. Percutaneous coronary intervention in anticoagulated patients via radial artery access. Catheter Cardiovasc Interv2009;73(1):44\u20137."},{"issue":"2","key":"i0730-2347-42-2-158-b9","series-title":"Catheter Cardiovasc Interv","first-page":"180","article-title":"Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy","volume":"60","year":"2003","unstructured":"Jessup\n DB, \n \n Coletti\n AT, \n \n Muhlestein\n JB, \n \n Barry\n WH, \n \n Shean\n FC, \n \n Whisenant\n BK. \n \n Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy. Catheter Cardiovasc Interv2003;60(2):180\u20134."},{"issue":"8","key":"i0730-2347-42-2-158-b10","series-title":"Eur Heart J","first-page":"1001","article-title":"Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment","volume":"29","year":"2008","unstructured":"Karjalainen\n PP, \n \n Vikman\n S, \n \n Niemela\n M, \n \n Porela\n P, \n \n Ylitalo\n A, \n \n Vaittinen\n MA, \n \n et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J2008;29(8):1001\u201310."},{"issue":"1","key":"i0730-2347-42-2-158-b11","series-title":"Interv Cardiol","first-page":"101","article-title":"Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a meta-analysis","volume":"3","year":"2011","unstructured":"Ahmed\n I, \n \n Gertner\n E, \n \n Nelson\n WB, \n \n House\n CM, \n \n Zhu\n DW. \n \n Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a meta-analysis. Interv Cardiol2011;3(1):101\u20139."},{"issue":"4","key":"i0730-2347-42-2-158-b12","series-title":"Chest","first-page":"840","article-title":"Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis","volume":"138","year":"2010","unstructured":"Jamula\n E, \n \n Lloyd\n NS, \n \n Schwalm\n JD, \n \n Airaksinen\n KE, \n \n Douketis\n JD. \n \n Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis. Chest2010;138(4):840\u20137."},{"issue":"18","key":"i0730-2347-42-2-158-b13","series-title":"Circulation","first-page":"2516","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","year":"2009","unstructured":"Anter\n E, \n \n Jessup\n M, \n \n Callans\n DJ. \n \n Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation2009;119(18):2516\u201325."},{"key":"i0730-2347-42-2-158-b14","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate) [Internet]. Available from http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm282724.htm [2011 Dec 7; cited 2015 Feb 10].","article-title":"FDA drug safety communication: safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate) [Internet]"},{"issue":"6","key":"i0730-2347-42-2-158-b15","series-title":"Ann Med","first-page":"428","article-title":"Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation","volume":"40","year":"2008","unstructured":"Rubboli\n A, \n \n Halperin\n JL, \n \n Airaksinen\n KE, \n \n Buerke\n M, \n \n Eeckhout\n E, \n \n Freedman\n SB, \n \n et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med2008;40(6):428\u201336."},{"issue":"3","key":"i0730-2347-42-2-158-b16","series-title":"Am Heart J","first-page":"477","article-title":"How does warfarin affect the activated coagulation time?","volume":"136","year":"1998","unstructured":"Chang\n RJ, \n \n Doherty\n TM, \n \n Goldberg\n SL. \n \n How does warfarin affect the activated coagulation time?\n Am Heart J\n 1998;136(3): 477\u20139."},{"issue":"9872","key":"i0730-2347-42-2-158-b17","series-title":"Lancet","first-page":"1107","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","year":"2013","unstructured":"Dewilde\n WJ, \n \n Oirbans\n T, \n \n Verheugt\n FW, \n \n Kelder\n JC, \n \n De Smet\n BJ, \n \n Herrman\n JP, \n \n et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet2013;381(9872):1107\u201315."},{"issue":"9775","key":"i0730-2347-42-2-158-b18","series-title":"Lancet","first-page":"1409","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial [published errata appear in Lancet 2011;377(9775):1408 and Lancet 2011;378(9785):30]","volume":"377","year":"2011","unstructured":"Jolly\n SS, \n \n Yusuf\n S, \n \n Cairns\n J, \n \n Niemela\n K, \n \n Xavier\n D, \n \n Widimsky\n P, \n \n et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial [published errata appear in Lancet 2011;377(9775):1408 and Lancet 2011;378(9785):30]. Lancet2011;377(9775):1409\u201320."},{"issue":"9745","key":"i0730-2347-42-2-158-b19","series-title":"Lancet","first-page":"975","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","year":"2010","unstructured":"Wallentin\n L, \n \n Yusuf\n S, \n \n Ezekowitz\n MD, \n \n Alings\n M, \n \n Flather\n M, \n \n Franzosi\n MG, \n \n et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet2010;376(9745):975\u201383."},{"issue":"5","key":"i0730-2347-42-2-158-b20","series-title":"Arch Intern Med","first-page":"397","article-title":"Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials","volume":"172","year":"2012","unstructured":"Uchino\n K, \n \n Hernandez\n AV. \n \n Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med2012;172 (5):397\u2013402."}],"container-title":["Texas Heart Institute Journal"],"original-title":[],"link":[{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/42\/2\/article-p158.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/thij\/article-pdf\/42\/2\/158\/1968426\/thij-13-3727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/42\/2\/article-p158.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/42\/2\/article-p158.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:31:56Z","timestamp":1730993516000},"score":1,"resource":{"primary":{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/42\/2\/article-p158.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":20,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.14503\/thij-13-3727","relation":{},"ISSN":["0730-2347","1526-6702"],"issn-type":[{"type":"print","value":"0730-2347"},{"type":"electronic","value":"1526-6702"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}